BRIEF-Oncolytics Biotech announces proposed public offering

* Expect to use net proceeds for working capital, expanding partnering activities, advancing clinical program for metastatic breast cancer Source text for Eikon: Further company coverage:

by reutersCOMPANYNEWS via Endless Supplies .Biz - News